Dr. Su Yon Jung has a Ph.D. degree from the University of Pittsburgh department of epidemiology and completed a post-doctoral at the University of Texas M.D. Anderson Cancer Center. During her graduate studies in Pittsburgh and later, she accumulated an array of research experiences using hospital-based metastatic breast cancer cohort data to identify prognostic factors for breast cancer survival. Her research interests include a focus on identifying cancer biomarkers associated with obesity and weight gain as potential strategies for cancer prevention. She has incorporated genetic approaches to evaluate the effect of gene-environmental interactions on the pathways connecting cancer-relevant biomarkers to cancer carcinogenesis, particularly their role in obesity and weight gain.
Jung SY, Vitolins MZ, Paskett ED, Chang S. Exogenous Estrogen as Mediator of Racial Differences in Bioactive Insulin-Like Growth Factor-I Levels Among Postmenopausal Women. J Gerontol A Biol Sci Med Sci. 2014 Sep 18. pii: glu164. [Epub ahead of print]
Paxton RJ, Jung SY, Vitolins MZ, Fenton J, Paskett E, Pollak M, Hays-Grudo J, Hursting SD, Chang S. Associations between time spent sitting and cancer-related biomarkers in postmenopausal women: an exploration of effect modifiers. Cancer Causes Control. 2014 Nov;25(11):1427-37. doi: 10.1007/s10552-014-0434-y. Epub 2014 Sep 20.
Jung SY, Hursting SD, Guindani M, Vitolins MZ, Paskett E, Chang S. Bioavailable insulin-like growth factor-I inversely related to weight gain in postmenopausal women regardless of exogenous estrogen. Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):534-44. doi: 10.1158/1055-9965.EPI-13-1053. Epub 2013 Dec 20.
Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM. Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension. 2012 Feb;59(2):205-11. doi: 10.1161/HYPERTENSIONAHA.111.171736. Epub 2011 Dec 19.
Jung SY, Sereika SM, Linkov F, Brufsky A, Weissfeld JL, Rosenzweig M. The effect of delays in treatment for breast cancer metastasis on survival. Breast Cancer Res Treat. 2011 Dec;130(3):953-64. doi: 10.1007/s10549-011-1662-4. Epub 2011 Jul 8.